Form 4: Davita Director Acquires DVA Common Stock

Davita Inc. Director Wendy Lee Schoppert reported the acquisition of 332 shares of common stock.

Summary

• Wendy Lee Schoppert, a Director of Davita Inc. (DVA), acquired 332 shares of common stock.
• The transaction occurred on March 15, 2026, with a reported price of $0 per share, indicating a likely grant or award.
• Following this transaction, Schoppert directly beneficially owns 332 shares of Davita Inc. common stock.
• Additionally, Schoppert indirectly beneficially owns 3,305 shares through the Wendy L. Schoppert Revocable Trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of shares, even if a grant, increases their vested interest and alignment with shareholder value.

Positives

• An insider (Director) acquired additional shares, which can be seen as a positive signal of confidence in the company's future prospects and alignment with shareholder interests.

Industry Context

StockSavvy.ai notes that insider acquisitions, especially by directors, are often interpreted by the market as a sign of management's belief in the company's future performance, contrasting with potential sales by executives at competitors like Fresenius Medical Care (FMS) or Baxter International (BAX) which might signal different internal outlooks.

Comparison to Industry Standards

• Insider buying at a $0 price is common for equity grants to directors as part of their compensation, aligning with practices seen at other healthcare providers such as HCA Healthcare or Tenet Healthcare, where directors often receive stock awards rather than cash for their service.

Stakeholder Impact

• Shareholders: Increased alignment between a director and shareholder interests due to increased stock ownership.

Key Dates

Recommendation

The acquisition of 332 shares by a director, likely as part of compensation, is a minor positive signal indicating continued alignment with shareholder interests. However, this transaction alone is not substantial enough to alter a broader investment thesis for Davita Inc., thus a 'hold' recommendation is appropriate, maintaining current positions while monitoring further developments.

Keywords

Davita Inc., DVA, Form 4, Insider Transaction, Director, Stock Acquisition, Beneficial Ownership